Merck KGaA (MRK)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
€117.55
Buy
€117.65
€-0.25 (-0.21%)
Prices updated at 15 Dec 2025, 10:01 CET
| Prices minimum 15 mins delay
Prices in EUR
Merck KGaA is a pharmaceutical and chemical company. It offers prescription medicines, diagnostics, and products used in allergen immunotherapy, specialty chemicals, and probiotic nutritional supplements.
0.68%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 59.01 |
| 2023 | 59.03 |
| 2022 | 61.65 |
| 2021 | 62.66 |
| 2020 | 61.02 |
| 2019 | 62.82 |
| 2018 | 63.72 |
| 2017 | 65.07 |
| 2016 | 65.38 |
| 2015 | 68.27 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 2.43 |
| 2024 | 2.90 |
| 2023 | 2.92 |
| 2022 | 3.61 |
| 2021 | 5.18 |
| 2020 | 3.53 |
| 2019 | 2.92 |
| 2018 | 2.54 |
| 2017 | 2.55 |
| 2016 | 2.94 |
| 2015 | 3.11 |
Price/Forward earnings (YTD)
13.89
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 5.55 |
| 2023 | 5.82 |
| 2022 | 7.08 |
| 2021 | 7.01 |
| 2020 | 4.64 |
| 2019 | 3.27 |
| 2018 | 9.31 |
| 2017 | 7.05 |
| 2016 | 4.27 |
| 2015 | 3.48 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.72 |
| 2023 | 1.82 |
| 2022 | 1.87 |
| 2021 | 2.13 |
| 2020 | 2.47 |
| 2019 | 2.46 |
| 2018 | 2.14 |
| 2017 | 2.54 |
| 2016 | 2.73 |
| 2015 | 2.98 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
